Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-02-21

Clinical Trial Update: Safety & Efficacy of Baclofen for Alcohol Withdrawal in Chronic Liver Disease With Active Alcohol Consumption

View source ↗

Summary

An ongoing clinical trial investigates the safety and efficacy of baclofen for alcohol withdrawal in patients with chronic liver disease who are actively consum…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BACLOFEN (Baclofen)

Snippet

Sponsor: Corporacion Parc Tauli | Conditions: Alcoholic Cirrhosis, Alcohol Abstinence | Status: ENROLLING_BY_INVITATION